semaglutide france becomes first EU country to reimburse anti-obesity drugs France Sets Obesity Care Framework

This makes it a triple agonist medication, the first of its kind

With a strong foothold in emerging markets and a potential 10x market growth, Ajanta aims to become a leading player in the global GLP-1 market by 2027.

Take the first step toward a healthier, happier you by joining our medically guided rapid weight

How prednisone affects Zepbound and tirzepatide, the blood sugar interaction, dose-timing rules, and a working protocol for short-term steroid courses.

Learn what food noise really means, why it happens, and how GLP-1 medications may help quiet constant thoughts about food, cravings, and overeating.

Treatment with retatrutide at 8 mg and 12 mg resulted in substantial reductions in liver fat in patients with obesity and metabolic dysfunction-associated steatotic liver disease, according to a presenter at The Liver Meeting